KPMA pledged to root out unfair drug trade deals.

Published: 2000-09-05 17:18:00

Updated: 2000-09-05 17:18:00

The KPMA expressed serious concerns about many uprising trend of unfair drug trade deals by taking advantages with chaotic chances in the markets caused by the ongoing strikes and disordered medical and pharmaceutical separation program. The KPMA indicated a definite will to eliminate such unreas...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK